Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Medical Devices

Public Workshop – Biofilms, Medical Devices and Anti-Biofilm Technology – Challenges and Opportunities, February 20, 2014

The Food and Drug Administration (FDA) announced a public Workshop entitled: “Biofilms, Medical Devices and Anti-Biofilm Technology – Challenges and Opportunities”. FDA co-sponsored this workshop with the Center for Biofilm Engineering (CBE) of Montana State University.

The biochemical and physiochemical characteristics of biofilms have been studied in-vitro, but the role that biofilms play in the development of device-related and other Healthcare Associated Infections, and their connection with development of resistant infections has been less widely studied until recent years, where research is increasingly making great strides.

With the increasing use of implanted and indwelling devices, understanding biofilm development on these devices and factors that impact biofilm formation is critical for protecting/promoting public health. Research on the basic science of biofilms may provide insight on device-associated biofilms, ultimately advancing research on technologies that are intended to prevent biofilm formation.

This State of the Art public workshop sought to share scientific information between the academic and healthcare communities, industry interested in developing products to address biofilm contamination, and US Government scientists.

Major topics covered at this workshop were:

  1. Research on biofilms and their public health impact
  2. Challenges faced by the scientific community, clinical community, government, and industry on addressing biofilm contamination of medical devices
  3. Critical areas of research that will address the scientific and clinical challenges faced by the stakeholders when developing technologies that are intended to prevent biofilm formation.

This public workshop may also form the basis for future discussions related to novel biofilm prevention technologies that could benefit US public health.

Date, Time and Location:

This meeting was held February 20, 2014, beginning at 8:00 a.m. at the following location:

FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, MD, 20993

The workshop is also available via webcast.

Back to Top Arrow


Back to Top Arrow


TimeSubjectName of Speaker
7:45–8:25 amRegistration and networking 
8:25–8:35 amWelcome and opening remarks - FDADr. Steve Pollack, Director, Office of Science & Engineering Laboratories, CDRH-FDA
8:35–8:45 amWelcome and opening remarks - CBEDr. Phil Stewart, Director, CBE, Montana State University
8:45–9:15 amKeynote addressDr. Javad Parvizi, Director, Clinical Research, Rothman Institute, Professor, Department of Orthopedic Surgery, Jefferson Medical College
9:15–9:45 amIntroduction to Biofilms and Medical Device Infections–HAIs and Public Health ImpactDr. Rodney Donlan, Director, CDC Biofilms Laboratory
9:45–10:15 amMedical Device Biofilms from a Clinician’s PerspectiveDr. Todd Heniford, Chief, Division of Gastrointestinal and Minimally Invasive Surgery, Carolina University Med Center
10:15–10:30 amBREAKBREAK
10:30–11:00 amBiofilm Explant AnalysisDr. Chuanwu Xi, Professor, University of Michigan, School of Public Health
11:00–11:30 pmBacterial Interactions with Medical Device MaterialsDr. Matthew Libera, Director, Stevens Laboratory of Multiscale Imaging, Professor, Stevens Institute of Technology
11:30–12:00 amIn-vitro Biofilm Reactors: Relation to In-vivo and Clinical OutcomesDr. Garth James, CBE Medical Projects Manager
12:00–12:20 pmCDRH/ODE perspectives on adding antibiofilm technology/agents to devicesMs. Angela Krueger, Policy Advisor–Product Jurisdiction Officer, CDRH/ODE
12:20–12:30 pmWrap-upDr. K. Scott Phillips, LCDR, USPHS, Regulatory Research Scientist, CDRH/OSEL
Morning presentations moderatorDr. Geetha Jayan, Senior Science Health Advisor - CDRH/OCD
1:15–1:45 pmEPA Development of a Biofilm Modelfor PesticidesDr. Stephen Tomasino, Senior Scientist, EPA Environmental Center, Microbiology Laboratory
1:45–2:05 pmAnti-biofilm TechnologiesDr. Dustin Williams, Chief Scientific Officer, Curza
2:05–2:25 pmAntimicrobial – ResistanceDr. John Chapman, Scientist, Ashland Chemical
2:25–2:45 pmStandard Methods for Testing Anti-Biofilm Technology: Progress and Future DirectionsDr. Paul Sturman, Industrial Coordinator & Research Professor, CBE
2:45–2:55 pmWrap up of afternoon sessionDr. Michael Waters, Reviewer, CDRH/OIR
Afternoon presentations moderatorDr. Thelma Valdes, Biomedical Engineer, CDRH/ODE
2:55–3:15 pmBREAKBREAK
3:15–4:45 pmPANEL DISCUSSION–Anti-biofilm technology and medical devicesPanel discussion moderator: Dr. K. Scott Phillips (LCDR, USPHS); Dr. Dinesh Patwardhan: CDRH/OSEL

Back to Top Arrow

Contact Us

For questions regarding workshop content please contact: Geetha Jayan, Center Science Council – Office of the Center Director, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 66, Silver Spring, MD 20993, 301-796-6300, OR Kenneth Scott Phillips, Division of Chemistry and Material Science - Office of Science and Engineering Laboratories, 10903 New Hampshire Avenue, Bldg. 66, 301-796-0238,

Back to Top Arrow

Page Last Updated: 01/12/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English